vs

Side-by-side financial comparison of HEALTHY CHOICE WELLNESS CORP. (HCWC) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.

HEALTHY CHOICE WELLNESS CORP. is the larger business by last-quarter revenue ($18.7M vs $13.2M, roughly 1.4× TriSalus Life Sciences, Inc.). HEALTHY CHOICE WELLNESS CORP. runs the higher net margin — -8.9% vs -73.9%, a 65.0% gap on every dollar of revenue. HEALTHY CHOICE WELLNESS CORP. produced more free cash flow last quarter ($-927.1K vs $-2.5M).

TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.

HCWC vs TLSI — Head-to-Head

Bigger by revenue
HCWC
HCWC
1.4× larger
HCWC
$18.7M
$13.2M
TLSI
Higher net margin
HCWC
HCWC
65.0% more per $
HCWC
-8.9%
-73.9%
TLSI
More free cash flow
HCWC
HCWC
$1.6M more FCF
HCWC
$-927.1K
$-2.5M
TLSI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCWC
HCWC
TLSI
TLSI
Revenue
$18.7M
$13.2M
Net Profit
$-1.7M
$-9.8M
Gross Margin
39.1%
86.7%
Operating Margin
-7.6%
-24.8%
Net Margin
-8.9%
-73.9%
Revenue YoY
59.8%
Net Profit YoY
3.5%
EPS (diluted)
$-0.05
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCWC
HCWC
TLSI
TLSI
Q4 25
$18.7M
$13.2M
Q3 25
$19.0M
$11.6M
Q2 25
$20.2M
$11.2M
Q1 25
$20.3M
$9.2M
Q4 24
$8.3M
Q3 24
$18.2M
$7.3M
Q2 24
$7.4M
Q1 24
$6.5M
Net Profit
HCWC
HCWC
TLSI
TLSI
Q4 25
$-1.7M
$-9.8M
Q3 25
$-1.2M
$-10.8M
Q2 25
$-339.4K
$-8.3M
Q1 25
$-712.4K
$-10.4M
Q4 24
$-10.1M
Q3 24
$-2.7M
$-2.4M
Q2 24
$-4.3M
Q1 24
$-13.2M
Gross Margin
HCWC
HCWC
TLSI
TLSI
Q4 25
39.1%
86.7%
Q3 25
38.8%
83.5%
Q2 25
40.1%
83.9%
Q1 25
38.8%
83.7%
Q4 24
85.3%
Q3 24
38.4%
86.3%
Q2 24
87.6%
Q1 24
85.0%
Operating Margin
HCWC
HCWC
TLSI
TLSI
Q4 25
-7.6%
-24.8%
Q3 25
-3.2%
-77.9%
Q2 25
-0.2%
-65.4%
Q1 25
-2.0%
-79.9%
Q4 24
-91.8%
Q3 24
-2.0%
-118.9%
Q2 24
-111.0%
Q1 24
-180.8%
Net Margin
HCWC
HCWC
TLSI
TLSI
Q4 25
-8.9%
-73.9%
Q3 25
-6.4%
-93.5%
Q2 25
-1.7%
-73.9%
Q1 25
-3.5%
-113.2%
Q4 24
-122.4%
Q3 24
-14.6%
-32.6%
Q2 24
-58.8%
Q1 24
-204.5%
EPS (diluted)
HCWC
HCWC
TLSI
TLSI
Q4 25
$-0.05
$-0.22
Q3 25
$-0.09
$-0.96
Q2 25
$-0.03
$-0.27
Q1 25
$-0.07
$-0.39
Q4 24
$-0.38
Q3 24
$-0.29
$-0.12
Q2 24
$-0.21
Q1 24
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCWC
HCWC
TLSI
TLSI
Cash + ST InvestmentsLiquidity on hand
$3.0M
$20.4M
Total DebtLower is stronger
$7.3M
Stockholders' EquityBook value
$7.3M
$-33.9M
Total Assets
$33.5M
$35.3M
Debt / EquityLower = less leverage
1.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCWC
HCWC
TLSI
TLSI
Q4 25
$3.0M
$20.4M
Q3 25
$3.0M
$22.7M
Q2 25
$4.7M
$26.5M
Q1 25
$1.8M
$13.0M
Q4 24
$8.5M
Q3 24
$1.8M
$11.3M
Q2 24
$16.5M
Q1 24
$4.0M
Total Debt
HCWC
HCWC
TLSI
TLSI
Q4 25
$7.3M
Q3 25
$8.5M
Q2 25
$9.7M
Q1 25
$10.6M
Q4 24
Q3 24
$11.6M
Q2 24
Q1 24
Stockholders' Equity
HCWC
HCWC
TLSI
TLSI
Q4 25
$7.3M
$-33.9M
Q3 25
$5.9M
$-26.7M
Q2 25
$5.8M
$-19.4M
Q1 25
$2.1M
$-34.4M
Q4 24
$-25.9M
Q3 24
$2.9M
$-20.4M
Q2 24
$-25.3M
Q1 24
$-36.0M
Total Assets
HCWC
HCWC
TLSI
TLSI
Q4 25
$33.5M
$35.3M
Q3 25
$33.7M
$36.5M
Q2 25
$36.4M
$41.3M
Q1 25
$34.1M
$28.6M
Q4 24
$24.0M
Q3 24
$33.2M
$27.5M
Q2 24
$32.4M
Q1 24
$17.9M
Debt / Equity
HCWC
HCWC
TLSI
TLSI
Q4 25
1.00×
Q3 25
1.43×
Q2 25
1.69×
Q1 25
5.01×
Q4 24
Q3 24
3.95×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCWC
HCWC
TLSI
TLSI
Operating Cash FlowLast quarter
$-855.1K
$-2.5M
Free Cash FlowOCF − Capex
$-927.1K
$-2.5M
FCF MarginFCF / Revenue
-5.0%
-19.1%
Capex IntensityCapex / Revenue
0.4%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$675.4K
$-19.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCWC
HCWC
TLSI
TLSI
Q4 25
$-855.1K
$-2.5M
Q3 25
$-308.7K
$-3.7M
Q2 25
$1.1M
$-7.3M
Q1 25
$1.1M
$-4.5M
Q4 24
$-5.7M
Q3 24
$-10.8M
Q2 24
$-13.4M
Q1 24
$-10.9M
Free Cash Flow
HCWC
HCWC
TLSI
TLSI
Q4 25
$-927.1K
$-2.5M
Q3 25
$-351.3K
$-3.9M
Q2 25
$988.6K
$-7.4M
Q1 25
$965.3K
$-5.3M
Q4 24
$-5.8M
Q3 24
$-11.0M
Q2 24
$-13.5M
Q1 24
$-10.9M
FCF Margin
HCWC
HCWC
TLSI
TLSI
Q4 25
-5.0%
-19.1%
Q3 25
-1.8%
-33.9%
Q2 25
4.9%
-66.1%
Q1 25
4.8%
-57.3%
Q4 24
-69.7%
Q3 24
-149.9%
Q2 24
-183.1%
Q1 24
-169.3%
Capex Intensity
HCWC
HCWC
TLSI
TLSI
Q4 25
0.4%
0.3%
Q3 25
0.2%
1.9%
Q2 25
0.4%
0.8%
Q1 25
0.6%
8.2%
Q4 24
0.6%
Q3 24
2.3%
Q2 24
0.8%
Q1 24
1.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCWC
HCWC

Retail Grocery$17.1M91%
Food Service Restaurant$1.7M9%

TLSI
TLSI

Segment breakdown not available.

Related Comparisons